Zeitro Introduces Scenario AI for Mortgage Origination

SAN FRANCISCO--(BUSINESS WIRE)-- Zeitro, a mortgage technology company, today announced the availability of Scenario AI, an agentic AI designed to help mortgage professionals evaluate borrower eligibility and compare underwriting guidelines.

Scenario AI brings AI-powered loan programs and eligibility evaluation into the professional mortgage origination workflow, querying thousands of programs simultaneously, enabling mortgage professionals to assess scenarios and allocate time and resources more effectively.

“For mortgage professionals, margin pressure is fundamentally an operational challenge,” said Bochen Wang, CEO of Zeitro. “Scenario AI helps mortgage professionals access borrower eligibility and program fit much more easily, reducing time and effort spent during the entire origination process. This release reflects our focus on applying AI in practical ways that support day-to-day origination workflows.”

Already in use by industry leaders like GMCC, Googain, and Mega Capital, Scenario AI is now publicly available to mortgage professionals, supporting a streamlined, evidence-based approach to evaluating borrower eligibility and program fit during the origination process.

About Zeitro

Founded in 2019, Zeitro is an AI-native mortgage technology company that provides digital software solutions for mortgage professionals. Built on deep industry expertise, Zeitro offers digital mortgage software solutions, including Scenario AI, LO Marketplace (BlueRate.ai), Pricing Engine (PPE), and Digital 1003 (POS), designed to support clarity, efficiency, and execution across the loan lifecycle. Zeitro operates as an independent platform and is SOC 2 certified, supporting secure and compliant mortgage origination workflows. Learn more at www.zeitro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260107205690/en/

MEDIA CONTACT:
Alex Arango
For Zeitro
678-781-7233
[email protected]

Source: Zeitro

You May Also Be Interested In

• Novak Djokovic Joins General Atlantic as Global Strategic Advisor
• Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
• VENU CEO J.W. Roth Featured on The Business Digest Radio Show & Podcast